Publicly traded biotechnology company developing medicines for genetic diseases; invests in pipeline subsidiaries.

San Francisco, United States · 3+ investments · 1 portfolio companies

Growth
Late Stage
Biotech
Genetic Medicine
Healthcare
Headquarters
San Francisco, United States
Founded
2015
Portfolio Company
1
Total Investments
3
Last Investment
Jan 2021
Geographic Focus
United States

Investment Thesis

Build and fund genetically-validated drug programs using portfolio theory to diversify pipeline risk across rare genetic diseases.

BridgeBio is a Venture Capital firm based in San Francisco, United States. It has made 3 investments in Biotech and Genetic Medicine, including Eidos Therapeutics.

Portfolio1

Co-investors6

Sign up to view co-investors

6 co-investors across 6 shared portfolio companies — who they back alongside, and how often they lead.

Hedge Fund ×2 · Venture Capital ×2 · Private Equity ×1 · 5 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

BridgeBio on Indexed.vc
<a href="https://indexed.vc/investors/bridgebio"><img src="https://indexed.vc/api/badge/investor/bridgebio" alt="BridgeBio on Indexed.vc" width="260" height="76" /></a>